NovaBay Pharmaceuticals, Inc. (NBY)
0.5298
-0.05
(-8.81%)
USD |
NYAM |
Feb 13, 16:00
0.5401
+0.01
(+1.94%)
After-Hours: 16:58
NovaBay Pharmaceuticals Free Cash Flow : -7.012M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cassava Sciences, Inc. | -83.91M |
| cbdMD, Inc. | -1.636M |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| Savara, Inc. | -99.27M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.84M |
| Cash from Financing (Quarterly) | -1.319M |
| Free Cash Flow Per Share (Quarterly) | -0.3131 |
| Free Cash Flow to Equity (Quarterly) | -1.768M |
| Free Cash Flow to Firm (Quarterly) | -1.763M |
| Free Cash Flow Yield | -240.7% |